Wind Turbines Benefit Crops

Posted: September 26, 2011 at 7:04 am

Ames Laboratory associate scientist Gene Takle talks about research into the effect of wind turbines on nearby crops. Preliminary results show the turbines may have a positive effect by cooling and drying the crops and assisting with carbon dioxide uptake.

Link:
Wind Turbines Benefit Crops

Sio Gene Therapies Announces Four Upcoming Oral Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy -... - May 1st, 2021
SOLA Biosciences Presented Positive ALS Animal Efficacy Data of SOL-257 at the 1st Annual MDA Insight in Research Investor Summit for Neuromuscular... - May 1st, 2021
Cell & Gene Therapy Technologies and Supplies Report 2021: Market Demand and Five-year Forecasts, Segmented by Technique, Region and Function -... - May 1st, 2021
Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the... - May 1st, 2021
CCRM and Amgen partner to advance emerging medical innovations - Canada NewsWire - May 1st, 2021
Rocket Pharmaceuticals Announces Upcoming Clinical Data Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy -... - May 1st, 2021
Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meeting 2021 - GlobeNewswire - May 1st, 2021
CRISPR Technology Market: Rise in focus on gene therapeutics is projected to contribute to the growth of the market - BioSpace - May 1st, 2021
New developments in the research field of immuno-oncology - Drug Target Review - May 1st, 2021
Precision BioSciences Announces Poster Presentation at the Upcoming American Society of Gene & Cell Therapy Annual Meeting - Business Wire - May 1st, 2021
Gene Therapy Market Worth US$ 20.9 billion UnivDatos Industry Analysis- by Size, Share, Growth, Trends, and Forecast 2021-2027 The Courier - The... - May 1st, 2021
FDA removes clinical hold on uniQure's haemophilia gene therapy - PMLiVE - May 1st, 2021
Sensorion Hosting Key Opinion Leader Webinar with Dr. Thomas Lenarz on the GJB2 Gene Related Hearing Loss on May 10, 2021 - Business Wire - May 1st, 2021
Hemophilia Gene Therapy Market: Global Industry Insights, Growth Prospects, Business Overview, Growth Rate and Forecasts 2027 KSU | The Sentinel... - May 1st, 2021
Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat in Greater China... - May 1st, 2021
Supporting Families Considering Participation in a Clinical Trial: Parent-Provider Perspectives - American Academy of Pediatrics - May 1st, 2021
Gene Therapy Market 2021-2026 to Witness High Growth in Near Future and Competitive Analysis | Leading Players Abeona Therapeutics, Audentes... - May 1st, 2021
Global Genes and Orphan Disease Center of the University of Pennsylvania to Convene Patient Group Leaders, Researchers, Clinicians and Industry for... - May 1st, 2021
New technology could allow more cancer patients to benefit from immunotherapy: U of T researchers - News@UofT - May 1st, 2021
BIS Research Study Highlights the Global Cell and Gene Therapy Drug Delivery Devices Market to Reach $10.82 Billion by 2030 investigated in the latest... - March 24th, 2021
BioCentriq partners with Kytopen to advance production and manufacturing of cell and gene therapies - NJBIZ - March 24th, 2021
Maze Therapeutics Reveals Its Initial Three Lead Programs Targeting Underlying Genetic Drivers of Life-Threatening Diseases - Business Wire - March 24th, 2021
Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications -... - March 24th, 2021
Life Edit Therapeutics Announces Award from Cystic Fibrosis Foundation - BioSpace - March 24th, 2021
Sarepta Therapeutics' Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Expression and... - March 24th, 2021
Sensorion Reports Full-Year 2020 Financial Results and Provides Business Highlights - Business Wire - March 24th, 2021
Diabetic Dogs Needed for Study that Could Reduce or Eliminate Insulin Injections - PRNewswire - March 24th, 2021
Actinium Announces Initiation of Patient Enrollment in Iomab-ACT Trial for Targeted Conditioning Prior to CD19 CAR T-Cell Therapy - PRNewswire - March 24th, 2021
ElevateBio Announces Chief Scientific Officer of Regenerative Medicine, Melissa Carpenter, PhD, Elected to the International Society for Stem Cell... - March 24th, 2021
With new results, Sarepta's 2nd gene therapy holds steady - BioPharma Dive - March 24th, 2021
Orgenesis Enters into Collaboration Agreement with MIDA to Deploy OMPULs for Point-of-Care Research and Development of Promising Cell and Gene... - March 24th, 2021
SparingVision Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting - GlobeNewswire - March 24th, 2021
FTD Trials: The Now and the Future | ALZFORUM - Alzforum - March 24th, 2021
Capsid titer quantification for AAV-based therapeutics - SelectScience - March 24th, 2021
At 11.5% CAGR, Genetic Testing Market Size Expected to Reach 23143.42 Mn by 2027 Says Brandessence Market Research - PRNewswire - March 24th, 2021
Hemophilia Gene Therapy Market is Thriving by World during Upcoming Year | Top Companies: Spark Therapeutics, Ultragenyx, Sangamo Therapeutics,... - March 24th, 2021
Science Drives Surging Interest in Psychedelic Therapeutics - PRNewswire - March 24th, 2021
First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimer's Disease - UC San Diego Health - February 19th, 2021
Selecta Biosciences and AskBio Initiate First-in-Human Dose-Escalation Study to Evaluate ImmTOR in Gene Therapy - PRNewswire - February 19th, 2021
UC San Diego: First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimers Disease - India Education Diary - February 19th, 2021
Charles River acquires Cognate BioServices to expand cell and gene therapy programs - BioPharma-Reporter.com - February 19th, 2021
Duchenne UK and Parent Project Muscular Dystrophy Award $350,000 to Address Immunological Challenges of Gene Therapy in Duchenne Muscular Dystrophy -... - February 19th, 2021
Global Gene Therapy Market Outlook to 2030 - by Therapeutic Approach, Type of Gene Therapy, Type of Vectors Used, Therapeutic Areas, Route of... - February 19th, 2021
Sensorion and Institut Pasteur announce new gene therapy collaboration - BioPharma-Reporter.com - February 19th, 2021
Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development - Business Wire - February 19th, 2021
Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and... - February 19th, 2021
Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition - BioSpace - February 19th, 2021
Most Elevated Read 2020 on Cancer Gene Therapy Market To Witness Robust Expansion Throughout The Forecast Period 2026 KSU | The Sentinel Newspaper -... - February 19th, 2021
Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease -... - February 19th, 2021
Global Genome Editing Market Is Expected to Reach USD 17.36 Billion by 2028 : Fior Markets - GlobeNewswire - February 19th, 2021
REGENXBIO Announces Additional Positive Interim Phase I/IIa and Long-Term Follow-Up Data of RGX-314 for the Treatment of Wet AMD - BioSpace - February 19th, 2021
IO Therapy Combinations Spurring Growth of the Global Immuno-oncology Market, 2020 Report - Upcoming Product Launches in Adoptive Cell Therapy Segment... - February 19th, 2021
The Europe cell and gene therapy market by revenue is expected to grow at a CAGR of over 23% during the period 20212026 - GlobeNewswire - February 17th, 2021
Global Gene Therapy Market Industry Trends and Forecasts 2020-2030: Big Pharma Players and Analysis of Gene Therapy Related Initiatives -... - February 17th, 2021
Global Gene Therapy Products Market Study including Growth Factors, New Top Players, Competitive Analysis by regions from 2021 to 2027 - The Courier - February 17th, 2021
REGENXBIO Announces Additional Positive Interim Phase I/IIa and Long-Term Follow-Up Data of RGX-314 for the Treatment of Wet AMD - The Baytown Sun - February 17th, 2021
Forge Biologics Receives FDA Fast Track, Orphan Drug, and Rare Pediatric Disease Designations for FBX-101 Gene Therapy for Patients with Krabbe... - February 17th, 2021
Europe Cell and Gene Therapy Market Industry Outlook and Forecast Report 2021-2026 with Data-driven Insights on the Impact of COVID-19 -... - February 17th, 2021
Dyno Therapeutics Announces Publication in Nature Biotechnology Demonstrating Use of Artificial Intelligence to Generate Unprecedented Diversity of... - February 17th, 2021
Global Cancer Gene Therapy Market Insights, Size Estimation, Research Insights, COVID-19 Impact and Future Trends By 2028 KSU | The Sentinel... - February 17th, 2021
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK - BioSpace - February 17th, 2021
Aldevron expands manufacturing capabilities in Madison - University of Wisconsin-Madison - February 17th, 2021
Rare Disease Gene Therapy Market: Increasing cases of genetic diseases to drive the market - PharmiWeb.com - February 17th, 2021
Sensorion Announces Third Gene Therapy Collaboration With Institut Pasteur Targeting Important Pediatric and Adult Deafness Segments - BioSpace - February 17th, 2021
ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome - GlobeNewswire - February 17th, 2021
News > Science > Visualisation of 'dancing DNA' - University of Leeds - February 17th, 2021
New study suggests genetic testing could be appropriate for all motor neuron disease (MND) patients whether or not they have a family history of the... - February 17th, 2021
Gyroscope Therapeutics Announces Positive Interim Data from Phase I/II FOCUS Trial of Investigational Gene Therapy GT005 - Business Wire - February 17th, 2021
Hemophilia A Market Domain to Witness Growth at a CAGR of 10.2% over the Study Period 2018-30 in the 7MM, Estimates DelveInsight - PRNewswire - February 17th, 2021
Global Cancer Gene Therapy Market Is Projected to Grow at an Exponential Rate over 2020 to 2028 | Market Top Players Analysis, Revenue, Application,... - February 17th, 2021
North America Virus Filtration Market 2020-2026: Surging Need for Virus Removal and Clearance amid COVID-19 Pandemic - PRNewswire - February 17th, 2021
Janssen R&D puts itself into a strong position in ophthalmology through research collaboration with Verana Health - pharmaceutical-technology.com - February 17th, 2021
CAR-T Cell Therapy Receives FDA Approval to Treat Certain Types of Large B-Cell Lymphoma - Curetoday.com - February 7th, 2021
Liso-cel Receives FDA Approval for the Treatment of R/R Large B-Cell Lymphoma - Cancer Network - February 7th, 2021
Europe Cell and Gene Therapy Market Size to Reach Revenues of USD 2.9 Billion by 2026 - Arizton - PRNewswire - February 7th, 2021
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight - Yahoo Finance - February 7th, 2021
Gene Therapy Market by Therapeutic Approach, Type of Gene Therapy, Type of Vectors Used, Therapeutic Areas, Route of Administration, and Key... - February 6th, 2021
Spark Therapeutics Announces First Participant Dosed in Phase 1/2 Study of Investigational Gene Therapy for Late-Onset Pompe Disease - BioSpace - February 6th, 2021
Sio Gene Therapies Announces First Patient Dosed in Clinical Trial of AXO-AAV-GM2 in Patients with Tay-Sachs and Sandhoff Disease (GM2 Gangliosidosis)... - February 6th, 2021
Regenerative Medicine Market to be Valued at USD 6.49 Billion by 2027 | The Escalating Burden of Chronic Diseases and Genetic Aberrations will be the... - February 6th, 2021

Comments are closed.